Autologous stem cell transplantation improves microcirculation in systemic sclerosis

被引:80
|
作者
Miniati, I. [1 ]
Guiducci, S. [1 ]
Conforti, M. L. [1 ]
Rogai, V. [1 ]
Fiori, G. [1 ]
Cinelli, M. [1 ]
Saccardi, R. [2 ]
Guidi, S. [2 ]
Bosi, A. [2 ]
Tyndall, A. [3 ]
Matucci-Cerinic, M. [1 ]
机构
[1] AOUC, Dept Biomed, Div Rheumatol, DENOthe Ctr, Florence, Italy
[2] AOUC, Bone Marrow Transplantat Unit, Florence, Italy
[3] Univ Basel, Dept Rheumatol, Basel, Switzerland
关键词
ENDOTHELIAL GROWTH-FACTOR; NAILFOLD CAPILLAROSCOPY; RAYNAUDS-PHENOMENON; PULMONARY-FIBROSIS; CYCLOPHOSPHAMIDE; SCLERODERMA; DISORDERS; PLACEBO; DISEASE; ANGIOGENESIS;
D O I
10.1136/ard.2007.082495
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: In systemic sclerosis (SSc) reduced capillary density decreases blood flow and leads to tissue ischaemia and fingertip ulcers. Nail fold videocapillaro-scopy (NVC) is a diagnostic and follow-up parameter useful to evaluate the severity, activity and the stage of SSc microvascular damage. Autologous haemopoietic stem cell transplantation (HSCT) is a new treatment for patients with severe diffuse cutaneous systemic sclerosis (dcSSc) refractory to conventional therapies. We aimed to evaluate the improvement of microvasculature after HSCT using NVC. Methods: A total of 16 patients with severe dcSSc with a "late'' videocapillaroscopy pattern underwent an immunesuppressive treatment: 6 were treated with HSCT and 10 with monthly pulse cyclophosphamide (CYC) 1 g for 6 months and then orally with 50 mg/day for further 6 months. NVC was performed before and after 3 months from the beginning of each treatment and then repeated every 3 months. Results: In all patients, before HSCT NVC showed large avascular areas and ramified capillaries and vascular architectural disorganisation ("late'' pattern). At 3 months after HSCT, the NVC pattern changed from "late'' into "active'', showing frequent giant capillaries (>6/mm) and haemorrhages, absence of avascular areas and angiogenesis phenomena; 1 year after HSCT, microvascular abnormalities were still in the "active'' pattern. In patients treated with CYC, no NVC modifications were observed during 24 months of follow-up and the pattern always remained "late''. Conclusions: These results indicate that HSCT with a high dose CYC regimen may foster vascular remodelling, while CYC at lower doses and with a chronic regimen does not influence the microvasculature.
引用
收藏
页码:94 / 98
页数:5
相关论文
共 50 条
  • [21] Autologous hematopoietic stem cell transplantation in systemic sclerosis: A reset to tolerance?
    van Rhijn-Brouwer, Femke C. C.
    Spierings, Julia
    van Laar, Jacob M.
    IMMUNOLOGY LETTERS, 2018, 195 : 88 - 96
  • [22] Renal Complications Following Autologous Stem Cell Transplantation for Systemic Sclerosis
    MacKenzie, Malcolm
    Atkins, Harold
    Wilk, Nikola
    Maltez, Nancy
    JOURNAL OF RHEUMATOLOGY, 2024, 51 : 24 - 25
  • [23] Renal Complications Following Autologous Stem Cell Transplantation for Systemic Sclerosis
    MacKenzie, Malcolm
    Atkins, Harry
    Maltez, Nancy
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2996 - 2998
  • [24] Choosing appropriate patients with systemic sclerosis for treatment by autologous stem cell transplantation
    Clements, PJ
    Furst, DE
    JOURNAL OF RHEUMATOLOGY, 1997, 24 : 85 - 88
  • [25] Autologous stem cell transplantation for severe systemic sclerosis: update on the ASTIS trial
    van Laar, JM
    Farge, D
    Tyndall, A
    BONE MARROW TRANSPLANTATION, 2005, 35 : S6 - S6
  • [26] Autologous stem cell transplantation for severe systemic sclerosis:: Update on the ASTIS trial
    Van Laar, JM
    Farge, D
    Tyndall, CB
    Sont, JK
    Saccardi, R
    Matucci-Cerinic, M
    Machold, K
    Arfi, S
    Sarrot-Reynauld, F
    Constans, J
    Roblot, P
    Quéré, I
    Durand, JM
    Sibilia, J
    Kaltwasser, J
    Peter, H
    Koetter, I
    Tony, H
    Fassas, A
    Van den Hoogen, FHJ
    Villiger, P
    Emery, P
    Tyndall, A
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 280 - 280
  • [27] Fibrosis regression after autologous haematopoietic stem cell transplantation in systemic sclerosis
    Vija, L.
    Verrecchia, F.
    Verola, O.
    de Raignac, A.
    Sibon, D.
    Michel, L.
    Farge, D.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S17 - S17
  • [28] Autologous stem cell transplantation for severe systemic sclerosis:: Update on the astis trial
    Van Laar, J. M.
    Farge, D.
    Bocelli-Tyndall, C.
    Sont, J. K.
    Saccardi, R.
    Miniati, I.
    Matucci-Cerinic, M.
    Machold, K.
    Arfi, S.
    Adoue, D.
    Sarrot-Reynauld, F.
    Constans, J.
    Roblot, P.
    Quere, I.
    Durand, J. M.
    Sibilia, J.
    Himsel, A.
    Kaltwasser, J.
    Peter, H.
    Koetter, I.
    Kleinert, S.
    Tony, H.
    Fassas, A.
    Voskuyl, A. E.
    Vonk, M.
    Van den Hoogen, F. H.
    Villiger, P.
    Weiner, S.
    Dass, S.
    Emery, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 527 - 527
  • [29] Autologous stem cell transplantation for severe systemic sclerosis: Update on the ASTIS trial
    van Laar, J. M.
    Farge, D.
    Bocelli-Tyndall, C.
    Sont, J. K.
    Saccardi, R.
    Miniati, I.
    Matucci-Cerinic, M.
    Voskuyl, A.
    van den Hoogen, F. H.
    Machold, K.
    Arfi, S.
    Sibilia, J.
    Sarrot-Reynauld, F.
    Constans, J.
    Roblot, P.
    Quere, I.
    Durand, J. M.
    Kaltwasser, J.
    Peter, H. H.
    Koetter, I.
    Tony, H.
    Fassas, A.
    Villiger, P.
    Weiner, S.
    Dass, S.
    Emery, P.
    Gratwohl, A.
    Tyndall, A.
    RHEUMATOLOGY, 2006, 45 : I155 - I156
  • [30] Autologous stem cell transplantation for severe systemic sclerosis: Update on the astis trial
    van Laar, J. M.
    Farge, D.
    Bocelli-Tyndall, C.
    Sont, J. K.
    Saccardi, R.
    Miniatis, I.
    Matucci-Cerinics, M.
    Machold, K.
    Arfi, S.
    Adoue, D.
    Sarrot-Reynauld', F.
    Constans, J.
    Roblot, P.
    Quere, I.
    Durand, J.
    Sibilia, J.
    Himsel, A.
    Kaltwasser, J.
    Peter, H.
    Koetter, I.
    Kleinert, S.
    Tony, H.
    Weiner, S.
    Fassas, A.
    Voskuyl, A. E.
    Vonk, M.
    Van den Hoogen, Fh.
    Dass, S.
    Emery, P.
    Villiger, P.
    Daikeler, T.
    Gratwohl, A.
    Tyndall, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 227 - 227